(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) reported positive topline results from a Phase 3 study of HETLIOZ (tasimelteon) 20 mg in adults with Delayed Sleep-Wake Phase Disorder (DSWPD).
Read the original report for the complete account of this story.